© 2000 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes
aLaval Hospital, Research Center, 2725, Chemin Sainte-Foy, Sainte-Foy, Québec, G1V 4G5, Canada
bINSERM U523, Institut de Myologie, IFR ‘Coeur Muscle et Vaisseaux’ no. 14, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
cService de Cardiologie, Hôpital Sainte Marguerite, Marseille, France
dService de Cardiologie, Hôpital Lariboisière, Paris, and Château-des-Côtes, Les Loges-en-Josas, France
* Corresponding author. Tel.: +1-418-656-8711, ext. 5447/+1-418-656-4760; fax: +1-418-656-4509 mohamed.chahine{at}phc.ulaval.ca
Familial long QT syndrome (LQTS) and Brugada syndrome are two distinct human hereditary cardiac diseases known to cause ventricular tachyarrhythmias (torsade de pointes) and idiopathic ventricular fibrillation, respectively, which can both lead to sudden death. Objective: In this study we have identified and electrophysiologically characterized, in patients having either LQTS or Brugada syndrome, three mutations in SCN5A (a cardiac sodium channel gene). Method: The mutant channels were expressed in a mammalian expression system and studied by means of the patch clamp technique. Results: The R1512W mutation found in our first patient diagnosed with Brugada syndrome produced a slowing of both inactivation and recovery from inactivation. The R4132G mutation found in our second patient who also presented Brugada syndrome, resulted in no measurable sodium currents. Both Brugada syndrome patients showed ST segment elevation and right bundle-branch block, and had experienced syncopes. The E1784K mutation found in the LQTS showed a persistent inward sodium current, a hyperpolarized shift of the steady-sate inactivation and a faster recovery from inactivation. Conclusion: The different clinical manifestations of these three mutations most probably originate from the distinct electrophysiological abnormalities of the mutant cardiac sodium channels reported in this study.
KEYWORDS Arrhythmia (mechanisms); Long QT syndrome; Membrane currents; Ventricular arrhythmias; Na-channel
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Biswas, D. DiSilvestre, Y. Tian, V. L. Halperin, and G. F. Tomaselli Calcium-Mediated Dual-Mode Regulation of Cardiac Sodium Channel Gating Circ. Res., April 10, 2009; 104(7): 870 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Benito, A. Sarkozy, L. Mont, S. Henkens, A. Berruezo, D. Tamborero, D. Arzamendi, P. Berne, R. Brugada, P. Brugada, et al. Gender Differences in Clinical Manifestations of Brugada Syndrome J. Am. Coll. Cardiol., November 4, 2008; 52(19): 1567 - 1573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-C. Chang, S. Acharfi, M.-H. Wu, F.-T. Chiang, J.-K. Wang, T.-C. Sung, and M. Chahine A novel SCN5A mutation manifests as a malignant form of long QT syndrome with perinatal onset of tachycardia/bradycardia Cardiovasc Res, November 1, 2004; 64(2): 268 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L Tan, C. R Bezzina, J. P.P Smits, A. O Verkerk, and A. A.M Wilde Genetic control of sodium channel function Cardiovasc Res, March 15, 2003; 57(4): 961 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.A. Groenewegen, C. R. Bezzina, J.P. van Tintelen, T. M. Hoorntje, M. M.A.M. Mannens, A. A.M. Wilde, Habo.J. Jongsma, and M. B. Rook A novel LQT3 mutation implicates the human cardiac sodium channel domain IVS6 in inactivation kinetics Cardiovasc Res, March 15, 2003; 57(4): 1072 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R Bezzina, M. B Rook, and A. A.M Wilde Cardiac sodium channel and inherited arrhythmia syndromes Cardiovasc Res, February 1, 2001; 49(2): 257 - 271. [Full Text] [PDF]
|
|
|
|
|
|
A. A.M. Wilde and M. W. Veldkamp What we can learn from individual resuscitated patients Cardiovasc Res, April 1, 2000; 46(1): 14 - 16. [Full Text] [PDF]
|
|